The Global Human Microbiome Market is poised for substantial expansion from 2025 to 2033, driven by growing research into the role of microorganisms in human health and disease. Increasing demand for microbiome-based diagnostics, therapeutics, probiotics, and personalized healthcare solutions is creating new opportunities across the pharmaceutical, biotechnology, and healthcare...
The global live biotherapeutic products (LBP) and microbiome contract development and manufacturing organization (CDMO) market is experiencing rapid growth, driven by increasing research in microbiome-based therapies and rising demand for outsourcing pharmaceutical development. Live biotherapeutics are emerging as a promising approach for treating a wide range of diseases, including...
